chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Mild fever of 99 degrees farenheit; Migraine; Sluggish; This spontaneous case was reported by a nurse and describes the occurrence of MIGRAINE (Migraine), SLUGGISHNESS (Sluggish) and PYREXIA (Mild fever of 99 degrees farenheit) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A and 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Psoriasis since 1990 and Osteoarthritis since 1990. Concomitant products included CYCLOBENZAPRINE HYDROCHLORIDE (FLEXERIL [CYCLOBENZAPRINE HYDROCHLORIDE]) from 1990 to an unknown date for Inflammation, HYDROCODONE from 1990 to an unknown date for Pain.   On 31-Mar-2021 at 12:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2021 at 12:30 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Apr-2021 at 3:00 PM, the patient experienced MIGRAINE (Migraine) and SLUGGISHNESS (Sluggish). On an unknown date, the patient experienced PYREXIA (Mild fever of 99 degrees farenheit). The patient was treated with IBUPROFEN ongoing since an unknown date for Adverse event, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) ongoing since an unknown date for Adverse event, at a dose of 1 dosage form. On 06-May-2021, MIGRAINE (Migraine) and SLUGGISHNESS (Sluggish) had resolved. At the time of the report, PYREXIA (Mild fever of 99 degrees farenheit) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Added other relevant history. Added time of first and second doses. Added concomitant medications. Added new event migraine. Updated reporter details. Updated patient details. Updated onset date, stop date and outcome of event sluggishness. On 07-Jun-2021: Follow up information received on 07-Jun-2021 contains no significant information.
Patient reports around 6 or 7 PM the evening of flu vaccine, developed muscle tremors in legs, neck pain, headache, and nausea. Symptoms lasted for 2 days "on and off."
Diarrhea; fatigue; sore arm; This is a spontaneous report from a contactable physician. A 3-decade-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (age at the time of vaccination was not provided) as DOSE NUMBER UNKNOWN, SINGLE for an unspecified indication. The medical history included infected with COVID-19 prior to being vaccinated from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient in her 20's received the Pfizer Covid-19 vaccine on an unspecified date and had severe reaction on an unspecified date. The patient had been infected with COVID-19 prior to being vaccinated on an unspecified date. When she received the vaccine, the patient developed diarrhoea and fatigue that lasted about 3 days on an unspecified date. She also had a sore arm that lasted about a day on an unspecified date. The outcome of the events was reported as recovered on an unspecified date.  Follow-up attempts completed. No further information expected. Information about lot/batch number has been requested.
On July 1, 2021 fifteen minutes after the shot started to get a headache and pain in her arm. Stated she felt dizzy and tired after the shot. She noticed that her arm and fingers were tingling. An hour after the shot her body aches began to increase and about 9:00pm her throat was swollen and her left side of her body was swollen. The next morning she felt nauseas and her body was still in pain. She felt cramping in her stomach and diaherria for days. Saturday morning still was experiencing stomach ache and also had a mild fever. During these days she had a headache the whole time. On Monday she still was experience cramping and the headache turned into a migraine that migrated from her neck all the way down her back. Went to the emergency but didn't do anything. Went to visit her doctor and she gave her a injection shot.
DIzziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (DIzziness) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product IBRUTINIB (IMBRUVICA) for Chronic lymphoid leukemia.    Concurrent medical conditions included Chronic lymphoid leukemia.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. and IBRUTINIB (IMBRUVICA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced DIZZINESS (DIzziness). At the time of the report, DIZZINESS (DIzziness) had resolved.            No concomitant medication information was provided.  On an unknown date, the patient received booster dose of Moderna COVID-19 vaccine.  The reporter's causality for the event of dizziness with Ibrutinib was reported as no reasonable possibility.  The route of administration of Ibrutinib was reported as subcutaneous.    It was unknown if patient was enrolled in COVID-19 vaccine trial or not.  No treatment information was provided.
Liver enzymes up; This spontaneous case was reported by a consumer and describes the occurrence of HEPATIC ENZYME INCREASED (Liver enzymes up) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced HEPATIC ENZYME INCREASED (Liver enzymes up). At the time of the report, HEPATIC ENZYME INCREASED (Liver enzymes up) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Hepatic enzyme: Up and went down.         Concomitant product use was not provided by the reporter. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. Treatment information was not provided. On unknown date, the patient experienced HURMIRA STOPPED WORKING with HUMIRA (ADALIMUMAB).
After no illness or abnormal behavior the day before, I found him almost comatose in his crib. We found out eventually his blood sugar was 32 and he was "diagnosed" with idiopathic ketotic hypoglycemia.
Patient reports having rash and generalized urticaria approximately 9 days after administration of first dose. Patient reports having controlled the symptoms with Benadryl "rash soap"  and hydrocortisone.
PATIENT WAS SEEN IN OFFICE 06/08/2011 C/O RASH ON EXTREMITIES AND TORSO X 2WEEKS. WAS DIAGNOSED WITH CONTACT DERMATITIS AND PRESCRIBED ACCLOVATE OINTMENT. WAS SEEN AGAIN IN OFFICE ON 06/13/2011 C/O RASH BEING WORSE. WAS REFERRED TO DERMATOLOGIST WHO THOUGHT RASH WAS A PROBABLE PAPULAR HYPERSENSITIVITY REACTION  OR QUESTIONABLE SCABIES. ORAL STEROIDS AND ELEMITE WAS PRESCRIBED. PT FOLLOWED UP WITH DERMATOLOGIST 2 DAYS LATER WHO THEN STATED RASH LOOKED "DIFFERENT" AND AT TIME THOUGHT IT MAY BE VARICELLA. A BIOPSY AND CULTURE OF THE AREA WAS DONE. ON 06/21 PT SEEN FOR FOLLOW UP. NO IMPROVEMENT OF RASH. CONTINUES TO SPREAD TO OTHER AREAS OF BODY. BIOPSY REPORT SAYS CONSISTENT WITH INSECT BITES HOWEVER THE CULTURE PCR SHOWED POSITIVE VARICELLA. PATIENT HAS STARTED ACYCLOVIR TODAY.
1st dose rec'd approximately 1500 today of Pfizer Lot ER 8732 Exp 7/21  1600 Patient drove back to waiting area after leaving with c/o vision changes BP 150/98 P 64 no other sx Pupils ERRL
Around 8am in the morning, I got a intramuscular shot in my left arm on/around the deltoid muscle. I stayed at the vaccine administration location for about 30 minutes to ensure I felt okay, and left. Around 8:45 am I noticed the left side of my face was going numb. By 9am, a 2" radius around my rear molars was completely numb. I immediately called the doctor who oversaw the administration and began constant communication with the doctor. I did not loose any functionality of muscles, my ability to talk, eat, or breathe. I simply felt like I had a very strong novacane shot to the upper rear gum and that numbness radiated out.  Under regular communications with the doctor and his team, I did daily check ins and updates with how I felt. The numbness started to wear off after 10 days of no medical intervention. 13 days post injection was the last day I felt any numbness. 14 days after injection I felt fine. I have not gotten the second shot. I have not felt any side effects since then.
arm became swollen, alot of pain and as the days went by he couldn't go to work due to couldn't raise his arm and was in deep pain
papular eruption (rash) on skin of anterir thighs where inj given;
Diagnosed with Covid; Diagnosed with Covid; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Lot number: EK4176), in left arm, as dose 2, single (Lot number: EL9262), in right arm and as dose 3 (booster), single (Lot number: FF2589), in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: TYLENOL COLD AND FLU DAYTIME, start date: 07May2022, stop date: 16May2022. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 07May2022 at 14:30, outcome "not recovered" and all described as "Diagnosed with Covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (07May2022) Positive, notes: Tested Covid positive 07May2022, began Paxlovid treatment with first evening dose; (12May2022) Negative, notes: Tested Covid negative 12May2022 and negative 14May2022; (14May2022) Negative, notes: Tested Covid negative 12May2022 and negative 14May2022; (19May2022) Positive, notes: Tested Covid positive 19May2022. Therapeutic measures were taken as a result of covid-19.  Clinical information: No known allergies. The patient was diagnosed with Covid, began Paxlovid treatment with first evening dose. Finished Paxlovid 12May2022 with last dose (morning). Symptoms worsened on 16May2022. COVID 19 Treatment was started on 07May2022 and stopped on 12May2022.
extremely heavy flow period that lasted 20 days; mild cramping usually occurring in the late morning nearly every day resulting in heavier discharge; slightly tired; sore arm; Achy joints; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EL9264; Expiration date was not reported), via an unspecified route of administration, administered in the left arm on 07Feb2021 16:00 (at the age of 51-years-old) as second dose, single for COVID-19 immunisation at a workplace clinic. Medical history included perimenopause in which the patient was having longer durations between periods but relatively normal (for her) in length of four to five days, environmental allergies and a heavy menstrual bleeding in which was described as one period about 14 months prior that was longer and heavier than she typically experienced however it only lasted for just over a week with slightly heavier discharge with some clumps; all of which from an unknown date and unknown if ongoing. Concomitant medication included paracetamol (TYLENOL) and ibuprofen; both taken for an unspecified indication, start and stop dates were not reported. The patient previously took amoxicillin; clavulanic acid (AUGMENTIN) and experienced drug allergy. The patient was previously vaccinated with the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EL3249) administered in the left arm on 17Jan2021 16:30 for COVID-19 immunisation. Patient was not pregnant. No other vaccine was given in four weeks. Patient was not COVID positive prior vaccination and was not tested for COVID post vaccination. On 09Feb2021, the patient experienced extremely heavy flow period that lasted 20 days. It was reported that the patient started her period approximately 48 hours before receiving the second dose of the vaccine and her flow was pretty typical until a couple days after her shot at which time she developed a much heavier flow with large, thick, dark clumps of bloody discharge. The patient also experienced mild cramping usually occurring in the late morning nearly every day resulting in heavier discharge, slightly tired, sore arm and achy joints on 09Feb2021. It was also reported that since the patient has history of heavy menstrual bleeding, she was not initially alarmed by the heavier flow. The patient began to have some concern as the period wore on but felt normal in every other way. No treatment was given for the events. The outcome of the events was recovered.
Vomiting; Nausea 8 days; Chills 8 days; Headache 8 days; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196), via an unspecified route of administration in the right arm on 18Jun2021 at 16:30 (at the age of 50-years-old), as a single dose for COVID-19 immunisation. Medical history included penicillin allergy, food allergy (wheat) and sulfonamide allergy. The patient did not receive any other medications in two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. On 19Jun2021, the patient experienced vomiting, nausea 8 days, chills 8 days and headache 8 days. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events vomiting, nausea 8 days, chills 8 days and headache 8 days were resolving at the time of this report.    No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a healthcare professional refers to an unknown number of patients (age and genders were not reported). On unknown dates, the patients were vaccinated with VARIVAX (Merck) (doses, routes of administration and lot numbers were not reported), that had been improperly stored. No adverse effect reported. A phone call was placed to the healthcare worker on 16-JUN-2015. A message was left with the receptionist requesting that the healthcare worker return the phone call. Additionally, a request was made for patient identifiers, lot number and expiration date and date of vaccination. All telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports from the same source. Additional information has been requested.
Patient seen in Emergency department for sensation of throat tightness. Mild shortness of breath. Nausea and back pain starting 4 hours after receiving flu shot. Similar reaction last year after vaccine. Mild erythema around shot injection site. ED diagnosis: Reaction to influenza immunization.
My daughter noticed both eyes were very red and asked me the question as to why.  I did not know my eyes were red, I was at home relaxing when she came through the door and noticed my eyes.
pt recvd vax & devel red, raised rash; tx w/ apap;
Fever, chills, myalgias moderately severe, lasted about 12 hours.  Over the next 3 days, pain at injection site and tender axillary lymph nodes.
Rule out cellulitis with pain, redness, swelling over right anterior thigh. Treated with Keflex.
At least 3-4 min after administration of Gardasil vaccine. Mom called us into room-pt was jerking and unresponsive to touch or voice-smelling salts were introduced and pt's arms and feet pointed inward and pt soon awoke pt skin was pale and clammy to touch BP-132/79 in R arm Pt advised to stay in office until feeling better.
This case was reported by a physician and described the occurrence of seizure in a 19-year-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline). On 28 January 2014 between 08:00 and 17:00, the subject received 1st dose of HAVRIX (unknown details). The physician could not name the hepatitis vaccine given; however, the lot number was found in the sales data for HAVRIX. On 31 January 2014, 3 days after vaccination with HAVRIX, the subject experienced seizure. In January 2014, within days after vaccination with HAVRIX, the subject experienced viral pneumonia. The date of onset of pneumonia was not reported. Per the physician, the subject was "ruled in for pneumonia. It was presumed to be viral." On 31 January 2014, at approximately 11:00, the subject experienced the first seizure that was not witnessed. At 12:30 on the same date, the subject experienced the second seizure that was witnessed at the emergency room. The subject was "started on medication and was given medication to abort the seizure." No details regarding the treatment medications were provided. The subject was hospitalised and the physician considered the event was life threatening and clinically significant (or requiring intervention). Relevant test results included: Per the physician, there was "evidence from a chest x-ray that [the subject] had pneumonia." The date of the chest x-ray was not reported. On 31 January 2014, the event of seizure was resolved. The outcome of the viral pneumonia was not reported. The vaccination course with HAVRIX was discontinued. The physician considered the event of seizure was possibly related to vaccination with HAVRIX. The physician did not report whether he considered the viral pneumonia related to HAVRIX.
heavyness and swelling of the arm; heavyness and swelling of the arm; Soreness of left arm; chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (heavyness and swelling of the arm), LIMB DISCOMFORT (heavyness and swelling of the arm), VACCINATION SITE PAIN (Soreness of left arm), CHILLS (chills) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PERIPHERAL SWELLING (heavyness and swelling of the arm), LIMB DISCOMFORT (heavyness and swelling of the arm), VACCINATION SITE PAIN (Soreness of left arm), CHILLS (chills) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) (oral) at a dose of 1 dosage form. At the time of the report, PERIPHERAL SWELLING (heavyness and swelling of the arm), LIMB DISCOMFORT (heavyness and swelling of the arm), VACCINATION SITE PAIN (Soreness of left arm), CHILLS (chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by reporter.   Reporter did not allow further contact
(A dose of expired vaccine should usually not be counted as valid and should be repeated. In general, doses of non-live (for example, inactivated, recombinant, or polysaccharide) vaccines may be repeated immediately. Repeat doses of most live vaccines should be given at least 4 weeks after the expired dose, because of the possibility that the vaccine antigen could still be viable. The above recommendation applies to live oral rotavirus vaccine, but with this caveat: the last dose of rotavirus vaccine should not be given to a child older than 8 months 0 days. Space a repeat dose less than 4 weeks if necessary to not exceed this maximum age.  If a capsule of expired live oral typhoid vaccine is taken, the entire 4-dose series should be repeated. There is no need to wait 4 weeks. As an alternative, a dose of the injected typhoid vaccine may be given.  Contact your immunization program and/or the vaccine manufacturer for specific guidance on revaccination. A manufacturer could recommend a "grace period" during which a dose of expired vaccine could still be counted.    ***Feedback about your experience with CDC-INFO is important to us and will help us continue to improve. Please rate your interaction by completing this short survey: No Physical symptoms reported, recommended to repeat dose in 4 weeks.
Received 2nd dose of Moderna COVID-19 vaccine on 01/27/2021 at 0830 am. Called on 01/28/2021 to report lightheadedness, weakness, chills and fever of 99.5. States that is 2 degrees above his normal body temp. Reports symptoms resolved in 24 hours.
Dad was fine until 7:30 11/20/21. Called me to say he had terrible stomach pain, blood pressure through the roof. He vomited 2x. Neighbor had him call for an ambulance and rushed to emergency. when I arrived his BP was still very high and his pain was still bad. He remained in emergency until Sunday when a bed became available.
Scratchy throat with cough, blood shot eyes that were tearing, extreme headache, feverish and body ache.
Fever (100.9), headache, chills, muscle aches, fatigue, loss of appetite, drowsiness, limitation of movement on injection site (left upper arm) due to pain.
Flaky, itchy, burning skin on cheeks, neck, upper chest, eyebrows, forehead, hairline.  Started one week after 2nd vaccination.  Seems to be caused by saliva on pillow.  Change pillow case every day, rinse mouth with Listerine each night, brush teeth morning and night.  Used Tinactin on it to help the itch, thinking it was a fungus.  My sisters one had Covid, the other did not but had the vaccines.  Both have had issues with their mouths, with recurring flare ups.  Mostly flaking, swelling, burning lips.  My pharmacist had me try a face masque using Head n Shoulders Shampoo, but it burned really baad so did ot use it any more.  I seem to control it with the daily regime I am using.
sore arm 5 days; This case was reported by a consumer and described the occurrence of pain in arm in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included defibrillator/pacemaker insertion (has had defibrillator placed back in 1994).   On 23rd July 2021, the patient received the 1st dose of Shingrix (intramuscular). On 23rd July 2021, less than a day after receiving Shingrix, the patient experienced pain in arm. On 28th July 2021, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were provided are as follows: The case was reported by patient himself. The patient received a dose of Shingrix in left arm and later on that evening had a sore left arm for 5 days. Referred patient to health care professional and provided CDC website. The reporter did not consented to follow-up.
Red area where injection was given.  Two other raised hives close to the injection site.  Very itchy and sore.  Hives are lightening but the itchiness is still ongoing at 4 days post.
Pain in left arm following flu shot administered on 9-26-13. Customer went to physician on 10/24/13 and was diagnosed with Neuralgia. Gabapentin and Diclofenac Sod EC were prescribed for 30 days and Hydro/APAP for 4 days. X-ray and lab work also ordered on 10/24/13.